• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病及相关疾病患者的血清尿酸水平。

Serum uric acid levels in Parkinson's disease and related disorders.

机构信息

Department of Neurology Dokkyo Medical University Mibu Japan.

Department of Neurology Dokkyo Medical University Koshigaya Hospital Koshigaya Japan.

出版信息

Brain Behav. 2016 Oct 31;7(1):e00598. doi: 10.1002/brb3.598. eCollection 2017 Jan.

DOI:10.1002/brb3.598
PMID:28127516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5256181/
Abstract

OBJECTIVE

Serum uric acid (UA) levels are reported to be decreased in patients with Parkinson's disease (PD) and multiple system atrophy (MSA). However, clinical correlates of serum UA levels are still unclear in PD-related disorders. We conducted a cross-sectional study to evaluate the associations between serum UA levels and disease duration, disease severity, and motor function among PD, MSA, and progressive supranuclear palsy (PSP) patients.

METHODS

A total of 100 patients with PD, 42 patients with MSA, 30 patients with PSP, and 100 controls were included in this study. Serum UA levels were determined, and associations among serum UA levels and disease duration, disease severity, and motor function in PD, PSP, and MSA patients were evaluated.

RESULTS

Serum UA levels were significantly lower in male PD, MSA, and PSP patients compared with the controls, but not in female patients. Serum UA levels were negatively correlated with disease duration and severity in MSA and PSP patients, but no correlations were observed in PD patients. The serum UA levels were significantly decreased in the tauopathy group (PSP patients) compared with the synucleinopathy group (PD and MSA patients) after adjusting for age, gender, and body mass index.

CONCLUSION

We found decreased serum UA levels in male patients with PD-related disorders (PD, MSA, and PSP) compared with male controls, and significant correlations between serum UA levels and disease severity in MSA and PSP patients.

摘要

目的

据报道,帕金森病(PD)和多系统萎缩(MSA)患者的血清尿酸(UA)水平降低。然而,PD 相关疾病中血清 UA 水平与临床相关性仍不清楚。我们进行了一项横断面研究,以评估 PD、MSA 和进行性核上性麻痹(PSP)患者的血清 UA 水平与疾病持续时间、疾病严重程度和运动功能之间的关系。

方法

本研究共纳入 100 例 PD 患者、42 例 MSA 患者、30 例 PSP 患者和 100 例对照者。测定血清 UA 水平,并评估 PD、PSP 和 MSA 患者血清 UA 水平与疾病持续时间、疾病严重程度和运动功能之间的关系。

结果

与对照组相比,男性 PD、MSA 和 PSP 患者的血清 UA 水平显著降低,但女性患者则不然。血清 UA 水平与 MSA 和 PSP 患者的疾病持续时间和严重程度呈负相关,但在 PD 患者中未观察到相关性。在校正年龄、性别和体重指数后,tau 病组(PSP 患者)的血清 UA 水平明显低于 synucleinopathy 组(PD 和 MSA 患者)。

结论

与男性对照组相比,我们发现 PD 相关疾病(PD、MSA 和 PSP)男性患者的血清 UA 水平降低,且 MSA 和 PSP 患者的血清 UA 水平与疾病严重程度之间存在显著相关性。

相似文献

1
Serum uric acid levels in Parkinson's disease and related disorders.帕金森病及相关疾病患者的血清尿酸水平。
Brain Behav. 2016 Oct 31;7(1):e00598. doi: 10.1002/brb3.598. eCollection 2017 Jan.
2
Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.帕金森病、多系统萎缩和进行性核上性麻痹患者血清胰岛素样生长因子-1 的临床相关性。
Parkinsonism Relat Disord. 2014 Feb;20(2):212-6. doi: 10.1016/j.parkreldis.2013.11.005. Epub 2013 Nov 14.
3
Low serum uric acid levels in progressive supranuclear palsy.进展性核上性麻痹患者血清尿酸水平降低。
Mov Disord. 2016 Mar;31(3):402-5. doi: 10.1002/mds.26466. Epub 2015 Dec 21.
4
[Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].[123碘标记间碘苄胍心肌闪烁显像在特发性帕金森病、多系统萎缩及进行性核上性麻痹病例中的应用]
Rinsho Shinkeigaku. 1997 Jun;37(6):476-82.
5
Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.帕金森病、进行性核上性麻痹和多系统萎缩患者自主神经功能障碍的比较。
Neurol Neurochir Pol. 2024;58(2):193-202. doi: 10.5603/pjnns.96939. Epub 2023 Dec 27.
6
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.进行性核上性麻痹与多系统萎缩和帕金森病认知缺陷的特征和进展。
J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. doi: 10.1007/s00702-019-02065-1. Epub 2019 Aug 20.
7
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.血清尿酸水平在神经退行性疾病中的研究:一项横断面研究。
J Alzheimers Dis. 2022;90(2):761-773. doi: 10.3233/JAD-220432.
8
A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.帕金森病、多系统萎缩和进行性核上性麻痹的昼夜节律系统的组织学研究。
JAMA Neurol. 2018 Aug 1;75(8):1008-1012. doi: 10.1001/jamaneurol.2018.0640.
9
Serum adiponectin levels between patients with Parkinson's disease and those with PSP.帕金森病患者与 PSP 患者之间的血清脂联素水平。
Neurol Sci. 2020 May;41(5):1125-1131. doi: 10.1007/s10072-019-04216-4. Epub 2020 Jan 2.
10
Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.进行性核上性麻痹中的神经性膀胱:与帕金森病和多系统萎缩的比较。
Neurourol Urodyn. 2018 Jun;37(5):1724-1730. doi: 10.1002/nau.23496. Epub 2018 Jan 22.

引用本文的文献

1
LC/MS/MS detection of uric acid oxidation metabolites to evaluate reactive oxygen and nitrogen species with application to pseudo-inflammation.采用液相色谱/串联质谱法检测尿酸氧化代谢产物以评估活性氧和活性氮,并应用于假性炎症。
J Clin Biochem Nutr. 2025 Jan;76(1):8-15. doi: 10.3164/jcbn.24-152. Epub 2024 Nov 9.
2
The impact of uric acid levels in the pathophysiology and its contribution to the prediction of diagnosis in restless legs syndrome.尿酸水平在不宁腿综合征病理生理学中的影响及其对诊断预测的贡献。
Sleep Biol Rhythms. 2024 Aug 22;23(1):39-45. doi: 10.1007/s41105-024-00549-6. eCollection 2025 Jan.
3
Elevated Serum Xanthine Oxidase and Its Correlation with Antioxidant Status in Patients with Parkinson's Disease.

本文引用的文献

1
Low serum uric acid levels in progressive supranuclear palsy.进展性核上性麻痹患者血清尿酸水平降低。
Mov Disord. 2016 Mar;31(3):402-5. doi: 10.1002/mds.26466. Epub 2015 Dec 21.
2
ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout.ABCG2 变异对帕金森病和痛风的发病年龄有相反的影响。
Ann Clin Transl Neurol. 2015 Mar;2(3):302-6. doi: 10.1002/acn3.167. Epub 2015 Jan 19.
3
The effects of uric Acid, serum vitamin d3, and their interaction on Parkinson's disease severity.尿酸、血清维生素 D3 及其相互作用对帕金森病严重程度的影响。
帕金森病患者血清黄嘌呤氧化酶水平升高及其与抗氧化状态的相关性
Biomolecules. 2024 Apr 18;14(4):490. doi: 10.3390/biom14040490.
4
Biomarkers of Parkinson's Disease: From Basic Research to Clinical Practice.帕金森病的生物标志物:从基础研究到临床实践。
Aging Dis. 2024 Aug 1;15(4):1813-1830. doi: 10.14336/AD.2023.1005.
5
Hyperuricemia may be associated with muscle wellness in older adults.高尿酸血症可能与老年人的肌肉健康有关。
Int Urol Nephrol. 2023 Nov;55(11):2981-2988. doi: 10.1007/s11255-023-03588-z. Epub 2023 Apr 7.
6
Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms.帕金森病伴抑郁患者的认知、运动症状和糖脂代谢。
J Neural Transm (Vienna). 2022 Jun;129(5-6):563-573. doi: 10.1007/s00702-021-02437-6. Epub 2021 Nov 27.
7
The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review.血清尿酸水平对特发性帕金森病和非典型帕金森病患者非运动症状发生和严重程度的影响——系统评价。
Medicina (Kaunas). 2021 Sep 16;57(9):972. doi: 10.3390/medicina57090972.
8
Serum Cystatin C as a Potential Predictor of the Severity of Multiple System Atrophy With Predominant Cerebellar Ataxia: A Case-Control Study in Chinese Population.血清胱抑素C作为以小脑性共济失调为主的多系统萎缩严重程度的潜在预测指标:一项中国人群的病例对照研究
Front Neurosci. 2021 Sep 10;15:663980. doi: 10.3389/fnins.2021.663980. eCollection 2021.
9
Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives.帕金森综合征的新型疗法——近期进展与未来展望
Front Mol Neurosci. 2021 Aug 26;14:720220. doi: 10.3389/fnmol.2021.720220. eCollection 2021.
10
Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson's Disease.脂蛋白相关磷脂酶A2是帕金森病患者的一个风险因素。
Front Neurosci. 2021 Apr 20;15:633022. doi: 10.3389/fnins.2021.633022. eCollection 2021.
Parkinsons Dis. 2015;2015:463483. doi: 10.1155/2015/463483. Epub 2015 Feb 24.
4
Uric acid relates to dopamine transporter availability in Parkinson's disease.尿酸与帕金森病中多巴胺转运体的可用性有关。
Acta Neurol Scand. 2015 Feb;131(2):127-31. doi: 10.1111/ane.12295. Epub 2014 Oct 7.
5
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patients.血清尿酸浓度与日本帕金森病患者的剂末波动有关。
J Parkinsons Dis. 2014;4(3):499-505. doi: 10.3233/JPD-140353.
6
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?血清尿酸与首发帕金森病患者的非运动症状有关吗?
Parkinsonism Relat Disord. 2014 Jul;20(7):772-5. doi: 10.1016/j.parkreldis.2014.03.016. Epub 2014 Mar 25.
7
Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population.尿酸与中国人群多系统萎缩的患病率相关,但与疾病进展无关。
J Neurol. 2013 Oct;260(10):2511-5. doi: 10.1007/s00415-013-7006-z. Epub 2013 Jun 26.
8
Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: a cross-sectional study.帕金森病和血管性帕金森综合征患者的血清尿酸:一项横断面研究。
Neuroimmunomodulation. 2013;20(1):19-28. doi: 10.1159/000342483. Epub 2012 Nov 14.
9
Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies.血清和脑脊液尿酸水平在突触核蛋白病与tau 病中的比较。
Acta Neurol Scand. 2013 Feb;127(2):e8-12. doi: 10.1111/ane.12012. Epub 2012 Sep 23.
10
Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.血清尿酸水平与中国帕金森病患者病情进展的相关性。
Chin Med J (Engl). 2012 Feb;125(4):583-7.